E-mail this page to a friend!
Senior Citizen Politics
Senators Want Antipsychotic Drug Use Better Controlled in Nursing Homes
‘…overuse of antipsychotics is a common and well-recognized problem that puts frail elders at risk and costs taxpayers
hundreds of millions of dollars each year’
May 23, 2012 – Senators from both parties joined with the Chairman of the Senate Special Committee on Aging, Sen. Herb
Kohl, D-Wis., to propose legislation to combat the costly and inappropriate – yet widespread – use of antipsychotic drugs in nursing homes.
Joining with Sen. Kohl, Sen. Chuck Grassley, R-Iowa, and Richard Blumenthal, D-Conn., offered the
amendment to S. 3187, the Food and Drug Administration Safety and Innovation Act.
It will require the Health and Human Services Secretary to issue standardized protocols for obtaining informed consent,
or authorization from patients or their designated health care agents or legal representatives, acknowledging possible risks and side effects
associated with the antipsychotic, as well as alternative treatment options, before administering the drug for off-label use.
Fewer Antipsychotic Drugs, More Nurses Will Improve
Care, Save Money in Nursing Homes
Senate Special Committee on Aging hearing focuses on long-term care for senior citizens; The Center for Medicare Advocacy
April 23, 2012
Obama Administration: A Plan To Prevent Alzheimer’s By 2025
Plan has been through months of
development since President Obama signed National Alzheimer’s Project Act
in January 2011, funding, however, an issue - see video - May 16, 2012
Physicians Wade Into Efforts To Curb Unnecessary Medical Treatments
Groups suggest one third of health care spending is for unnecessary treatments; Dr. Donald Berwick, the former head of
Medicare, called the campaign "a game changer." - April 4, 2012
House Bill Would Make Colonoscopy, Polyp Removal Free for Medicare Patients
Groups want to allow removal of polyps during procedure with no unexpected co-pay
March 1, 2012
Politics for Senior Citizens
“The overuse of antipsychotics is a common and well-recognized problem that puts frail elders at risk and costs
taxpayers hundreds of millions of dollars each year,” Kohl said.
“We need a new policy that helps to ensure that these drugs are being appropriately used to treat people with mental
illnesses, not used to curb behavioral symptoms of Alzheimer’s or other dementias.”
While the Food and Drug Administration (FDA) has approved antipsychotic drugs to treat an array of psychiatric
conditions, numerous studies conducted during the last decade have concluded that these medications can be harmful when used by frail elders
with dementia who do not have a diagnosis of serious mental illness.
The FDA has issued two “black box” warnings citing increased risk of death when these drugs are used to treat elderly
patients with dementia.
The FDA issued a Public Health Advisory for atypical antipsychotic medications. The FDA determined that death rates are
higher for elderly people with dementia when taking this medication. A review of data has found a risk with conventional antipsychotics as
well. Antipsychotic medications are not FDA-approved for the treatment of behavioral disorders in patients with dementia.
Last year, the Health and Human Services Office of the Inspector General (HHS OIG) issued a report showing that over a
six-month period, 305,000, or 14 percent, of the nation’s 2.1 million elderly nursing home residents had at least one Medicare or Medicaid
claim for atypical antipsychotics.
The HHS OIG also found that 83 percent of Medicare claims for atypical antipsychotic drugs for elderly nursing home
residents were associated with off-label conditions and that 88 percent were associated with a condition specified in the FDA box warning.
Further, it showed that more than half of the 1.4 million claims for atypical antipsychotic drugs, totaling $116.5 million, failed to comply
with Medicare reimbursement criteria.
The amendment also calls for a new prescriber education program to promote high-quality, evidence-based treatments,
including non-pharmacological interventions. The prescriber education programs would be funded through settlements, penalties and damages
recovered in cases related to off-label marketing of prescription drugs.
“This amendment responds to alarming reports about the use of antipsychotic drugs with nursing home residents,” Grassley
said. “It’s intended to empower these residents and their loved ones in the decisions about the drugs prescribed for them.”
“This measure is responsive to mounting evidence that antipsychotics are being misused and overused in the nursing homes
we trust to care for our loved ones,” added Blumenthal.
“The amendment will do what is necessary to curb this deeply concerning practice, putting the power to make key health
care decisions back into the appropriate hands and eliminating unnecessary costs to taxpayers.”
>> For details of the amendment -
>> About Mental
Health Medications, National Institute of Mental Health
Financial Relief for Volkswagen Diesel Owners
You may be eligible for money damages if you owned or leased one of these VW, Porsche or Audi vehicles.
In the major scandal of 2015, Volkswagen cheated you and the world. They rigged diesel emission controls so you, nor regulators, would know how much pollution their cars were adding to our environment.
They were caught and have reserved $7.3 billion to help "make it right" with victims.
If you owned or leased one of these vehicles, contact us now.
Janicek Law attorneys are actively pursuing these cases against VW. Do Not Wait...
Janicek Law Firm, PC
(Call toll free)
VW Jetta SportWagen (2009–2014)
VW Golf (2010-2015)
VW Golf SportWagen (2015)
VW Beetle (2012–2015)
VW Passat (2012-2015)
Audi A3 (2010-2015)
VW Touareg (2009–2016)
Porsche Cayenne (2015)
Audi A6, A7, A8, Q5 Quattro (2016)
Click to More Senior News on the